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HISTAMINE AND TNF-α RELEASE BY RAT PERITONEAL MAST CELLS
STIMULATED WITH TRICHOMONAS VAGINALIS
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Summary:
Mast cells have been reported to be predominant in the vaginal 
smears of patients infected with T. vaginalis. In this study, we 
investigated whether T. vaginalis could induce mast cells to migrate 
and to produce TNF-α and histamine. Rat peritoneal mast cells 
(RPMC), a primary mast cell, were used for the study. T. vaginalis 
induced an increase in chemotactic migration of the mast cells 
toward excretory and secretory product (ESP) of T. vaginalis, and the 
mast cells activated with T. vaginalis showed an increased release of 
histamine and TNF-α. Therefore, mast cells may be involved in the 
inflammatory response caused by T. vaginalis.
KEY WORDS: Trichomonas vaginalis, rat, mast cell, migration, histamine, 
TNF-α.
Résumé : HISTAMINE ET TNF-α SECRÉTÉS PAR LES MASTOCYTES 
PÉRITONÉAUX STIMULÉS PAR TRICHOMONAS VAGINALIS CHEZ LE RAT
Les mastocytes sont observés en quantité importante dans 
les sécrétions vaginales de patientes infectées par T. vaginalis. 
Cette étude explore pourquoi T. vaginalis induit la migration 
des mastocytes et leur production de TNF-α et d’histamine. Des 
mastocytes péritonéaux du rat ont été utilisés pour cette étude. 
Les produits d’excrétion-sécrétion de T. vaginalis induisent une 
augmentation de la migration chémotactique des mastocytes, et les 
mastocytes ainsi activés par T. vaginalis augmentent leur production 
d’histamine et de TNF-α. Les mastocytes seraient donc impliqués 
dans la réaction inflammatoire à T. vaginalis.
MOTS-CLÉS : Trichomonas vaginalis, rat, mastocyte, migration, histamine, 
TNF-α.
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INTRODUCTION 
T richomonas vaginalis is the most common curable sexually-transmitted infection (STI) worldwide (Johnston & Mabey, 2008). In 
pregnant women, trichomonads are implicated in the 
premature rupture of membranes, premature delivery, 
and the delivery of low-birth weight infants (Cotch et 
al., 1997; Moodley et al., 2002). In addition, trichomo-
niasis has been implicated as a risk factor for human 
immunodeficiency virus transmission (McClelland et 
al., 2007). More than 174 million people worldwide 
are infected by this parasite annually, and the pre-
valence rate was recently found to be 10.4 % in the 
area of Guri, Korea (Johnston & Mabey, 2008; Ryu & 
Min, 2006).
Mast cells have been implicated as effector cells in 
response to multiple nematodes and other parasitic 
organisms. Specific mast cell proteases such as mast 
cell protease (MCP-9 and MCP-1) have been shown to 
have crucial roles in mediating responses to nematode 
infection. (McDermott et al., 2003; Lawrence et al., 
2004). However, their role in protozoan infections is 
less well described (Li et al., 2004). In trichomoniasis, 
it has been reported that an increased frequency of 
mast cells are commonly found in the vaginal smears 
and vaginal walls of infected women (Kobayashi et 
al., 1983; Karagiosov & Pophristova, 1978; Dawicki & 
Marshall, 2007). Although these observations suggest 
that mast cells may be involved in the cellular reaction 
to vaginal trichomoniasis, mast cell infiltration and 
their role in immunity against trichomoniasis has not 
yet been clearly characterized.
Mast cells are strategically located at sites that inter-
face with the external environment, and are closely 
associated with blood vessels and nerves. As long-
lived cells, they can have an enormous impact on the 
tissue microenvironment through the selective release 
of a wide variety of preformed and newly derived 
mediators including potent proteases, cytokines, che-
mokines, and arachidonic acid metabolites (Dawicki 
& Marshall, 2007). Among these immunomodulatory 
molecules, TNF-α and histamine are prototype media-
tors secreted by activated mast cells and induce an 
inflammatory reaction. 
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However, to date, no reports have described TNF-α 
or histamine production by mast cells after stimula-
tion with T. vaginalis. In this study, to elucidate the 
involvement of mast cells in T. vaginalis infection, 
we examined TNF-α and histamine production in rat 
peritoneal mast cells activated by T. vaginalis and 
measured the chemotactic migration of mast cells 
towards T. vaginalis. 
MATERIALS AND METHODS
REAGENTS
PMA, calcium ionophore A23187, percoll, and hep-tane were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Fetal bovine serum (FCS) 
and horse serum were purchased from Gibco BRL (Gai-
thersburg, MD). Recombinant rat stem cell factor was 
purchased from PeproTech Asia (Israel), and o-phthaldi-
aldehyde was purchased from Biochemica (Austria).
CELL CULTURES
The Trichomonas vaginalis isolate T016 used in the 
present study was grown in a complex trypticase-yeast 
extract-maltose (TYM) medium supplemented with 
10 % heat-inactivated horse serum. The excretory-
secretory products (ESP) of T. vaginalis were obtained 
by suspending trophozoites (1 x 107/ml) in RPMI 1640, 
culturing them at 37 °C for 1 h, and then centrifuging 
at 10,000 g for 30 min. The resulting supernatants 
were passed through a 0.22-µm filter. Undiluted ESP 
called 100 % ESP. Phosphate buffered saline (PBS) was 
used for dilution of the 100 % ESP, and percent of ESP 
depends on the amount of PBS. 
ANIMALS
Wistar rats were purchased from Samtako (Kyung 
Gi-Do, Korea). They were housed 5-10 per cage in a 
laminar air-flow room maintained at a temperature of 
22 ± 4 °C and relative humidity of 55 ± 5 % throughout 
the study.
RAT PERITONEAL MAST CELL (RPMC) PREPARATION
RPMCs were isolated as described previously (Kim 
& Lee, 1999). In brief, Wistar rats were anesthetized 
by ether and injected with 50 ml of Tyrode buffer 
(137 mM NaCl, 5.6 mM glucose, 12 mM NaHCO3, 
2.7 mM KCl, 0.3 mM NaH2PO4, and 0.1 % gelatin) into 
the peritoneal cavity, and the abdomen was gently 
massaged for about 90 s. The peritoneal cavity was 
carefully opened, and the fluid containing peritoneal 
cells were aspirated by Pasteur pipette. The peritoneal 
cells were sedimented at 150 g for 10 min at 4 °C and 
resuspended in Tyrode buffer. Mast cells were sepa-
rated from the major components of rat peritoneal cells, 
i.e. macrophages and small lymphocytes, according to 
the method described by Yurt et al. (1977). In brief, 
peritoneal cells were suspended in 1 ml of Tyrode 
buffer, layered on 2 ml of 45 % percoll (density 1.12) 
and centrifuged at 4 °C for 15 min at 400 g. The cells 
remaining at the buffer-percoll interface were aspirated 
and discarded; the cells in the pellet were washed and 
resuspended in 1 ml of Tyrode buffer. Mast cell pre-
parations were approximately 96 % pure as assessed 
by toluidine blue staining. More than 97 % of the 
cells were viable as measured by trypan blue uptake. 
TRANSMISSION ELECTRON MICROSCOPY
Transmission electron microscopy was conducted 
as follows: RPMC (3 × 106) were reacted with live 
trichomonads (1.5 × 106) or T. vaginalis ESP (25 %) 
incubated for 3 h, fixed with 3 % glutaraldehyde in 
0.1 M phosphate buffer (pH 7.3) for 3 h, washed three 
times, and postfixed with 1 % osmium tetroxide in 
0.1 M phosphate buffer for 2 h. The specimens were 
then dehydrated in an ethanol gradient, embedded in 
Epon, and polymerized at 60 °C for 48 h. Ultra-thin 
sections (50-70 nm) were stained with 1 % uranyl 
acetate followed by lead citrate, and examined with 
a transmission electron microscope (H-7600S, Hitachi, 
Japan) (Kang et al., 2006).
ASSAY OF HISTAMINE RELEASE
Histamine content was measured by the o-phthaldi-
aldehyde spectrofluorometric procedure (Shore et al., 
1959; Schwartz et al., 1981; Na et al., 2005). RPMC sus-
pensions (2 × 105) were reacted with T. vaginalis ESP 
(10 %, 25 %, 50 %), and live trichomonads (1 × 105, 
4 × 105) for 30 min. The reaction was stopped by 
cooling the tubes on ice. The cells were separated 
from the released histamine by centrifugation at 400 g 
for 5 min at 4 °C. Residual histamine in the cells was 
released by disrupting the cells with 1 % Triton-X 100 
and centrifuged at 400 g for 5 min at 4 °C. In brief, 
the culture supernatant (250 µl each) were mixed 
with 225 µl of 0.1 N HCl and 25 µl of 60 % perchloric 
acid and centrifuged 22,000 g at 4 °C for 20 min. The 
collected supernatant (400 µl), water (1.5 ml), and 
n-butanol (5 ml) were put into a tube containing NaCl 
(0.6 g) and 5 N NaOH (250 µl), and mixed for 20 min 
and centrifuged at 385 g for 5 min at 4 °C. The col-
lected supernatant (4 ml) and heptane (5 ml) were put 
into a tube containing 1.5 ml of 0.1 N HCl, and mixed 
for 20 min and centrifuged as above. The liquid col-
lected from bottom level (150 µl), 1 N NaOH (30 µl), 
and 7.5 µl of 1 % o-phthaldialdehyde (OPT) were put 
into optiplate 96-well plates (Costar) and incubated for 
3 min at 30 °C. To stop the reaction, 3 N HCl (15 µl) 
was added and the light emission was measured in 
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a spectrofluorometer. The fluorescent intensity was 
measured at 440 nm (excitation at 360 nm) in a spec-
trofluorometer (Varioskan Flash, Thermo Electron Cor-
poration, Mass, USA). Histamine release was calculated 
as a percentage (released histamine) of total histamine 
(= extracellular plus intracellular histamine).
TNF-α EXPRESSION
TNF-α protein in supernatants from RPMCs (2 × 105) 
stimulated with live trichomonads (5 × 105, 10 × 105) 
or T. vaginalis ESP (10 %, 25 %, 50 %) was measured 
by ELISA using a commercial kit (BD Biosciences) 
according to the manufacturer’s instructions. 
MRNA expressions of TNF-α was measured by RT-
PCR after RPMC (1 × 106) coincubated with 50 % 
ESP of T. vaginalis for 1 h or 2 h. Total RNA was 
extracted from cells using Trizol reagent (Invitrogen, 
Carlsbad, California, USA) according to the method 
described previously (Han et al., 2009). Primer 
sequences and PCR conditions used for amplifica-
tion of β-actin and TNF-α were as follows: β-actin 
(sense) 5’-AGCCATGTACGTAGCCATCC-3’, (antisense) 
5’-CTCTCAGCTGTGGTGGTGAA-3’; TNF-α (sense) 
5’-CTCTTCAAGGGACAAGGCTG-3’, (antisense) 5’-
TGGAAGACTCCTCCCAGGTA-3’; PCR conditions of 
initial DNA denaturation at 94 °C for 5 min and 35 
rounds of denaturation (98 °C for 15 sec), annealing 
(53 °C for 30 sec), and extension (72 °C for 35 sec). 
The PCR products were electrophoresed in 2 % aga-
rose gel containing 0.5 µl/ml ethidium bromide, and 
photographed under ultraviolet light. The band inten-
sity was quantified using the Quantity One program 
(BioRad, Hercules, California, USA) (Han et al., 2009).
CHEMOTAXIS ASSAY
To test migration of the mast cells, a cell migration 
assay was performed using a 24-well microplate. The 
lower wells were filled with 500 µl buffer containing 
T. vaginalis ESP (10 %, 25 %, 50 %) or recombinant rat 
SCF (100 ng/ml). A polyvinylpyrrolidone-free polycar-
bonate filter (Millipore, Ireland) with an 8 µl pore-size 
was then placed over the lower well. The upper wells 
were filled with 200 µl of RPMCs (2 × 105 total cells) 
in MEM containing 10 % fetal bovine serum. The plate 
was incubated for 4 h at 37 °C. After the filter was 
removed, the cells adhering to its upper surface were 
wiped off with a filter wiper. The filter was dried, fixed, 
and stained with 0.5 % toluidine blue. The cells from 
four randomly selected fields per well were counted 
using a light microscope. The chemotactic index was 
calculated by comparing the number of cells that had 
migrated in the experimental sample to the number 
of cells that had migrated in the control.
STATISTICAL ANALYSIS
The results are expressed as means ± SEM of three 
to four independent experiments. The Mann-Whitney 
U-test was used for statistical analysis, and a P value 
of < 0.05 was considered statistically significant.
RESULTS
ELECTRON MICROSCOPIC FEATURES OF RPMC
Freshly isolated RPMCs contained many spherical electron-dense granules in the cytoplasm. Mast cell treated with live trichomonads or T. vagi-
nalis ESP showed decreased number of electron-dense 
granules. T. vaginalis ESP caused loss of a few gra-
nule from RPMC. In case of RPMC treated with live 
trichomonads, several granules were swollen and less 
electron dense. The presented data suggest that the 
T. vaginalis induces the exocytosis of mast cell-specific 
granules (Fig. 1). 
Fig. 1. – Electron microscopy of rat peritoneal mast cells (RPMC). (A) untreated RPMC, (B) & (C) RPMC treated with live trichomonads and 
25 % ESP of T. vaginalis for 3 h, respectively. Typical mast cell-specific granules (granules filled with electron-dense material) are present 
in untreated RPMC, which were presumably exocytosed after stimulation by live trichomonad or T. vaginalis ESP. Scale bar: 0.5 µm.
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HISTAMINE RELEASE
Among the preformed and newly synthesized inflam-
matory substances released upon the degranulation 
of mast cells, histamine remains the best-characte-
rized and most potent vasoactive mediator implicated 
in the acute phase of anaphylaxis (Petersen et al., 
1996). When RPMCs were stimulated with T. vagi-
nalis ESP (10 %, 25 %, 50 %), or live trichomonads 
(1 × 105, 4 × 105) for 30 min, the mast cells showed 
a significant increase in histamine release compared 
with untreated RPMCs except of that of 50 % ESP 
with decreased level. As expected, the combination 
of PMA and A23187, used as a positive control, 
significantly increased histamine release by RPMCs 
to nine times more compared with that of medium 
alone (Fig. 2). 
TNF-α PRODUCTION
Activated mast cells produce the multipotent cyto-
kine TNF-α (Gordon & Galli, 1991). T. vaginalis ESP 
and live trichomonads induced an increase in TNF-α 
production by RPMCs compared with that of medium 
alone, while live trichomonads induced the highest 
level of production. When RPMCs were stimulated 
with live trichomonads for 60 min, TNF-α mRNA 
expression increased by two-fold compared with 
medium alone (Fig. 3). 
CHEMOTAXIS ASSAY
Because cell migration is a pivotal step in the inflam-
matory response, we investigated the alteration of 
RPMC migration after stimulation with T. vaginalis. 
T. vaginalis ESP induced increased migration of 
RPMCs, and was maximally active at a concentration 
of 50 %. As expected, stem cell factor (SCF), used 
as positive control, increased the chemoattraction of 
RPMCs (Fig. 4). 
Fig. 2. – Histamine release from rat peritoneal mast cells stimulated 
with T. vaginalis (excretory-secretory products of T. vaginalis, and 
live trichomonads) for 30 min. P: PMA (50 nM) + A23187 (1 µM); 
C: RPMC alone. * p < 0.05 versus RPMC alone.
Fig. 3. – (A). TNF-α production induced by rat peritoneal mast cells stimulated with T. vaginalis (excretory-secretory products of T. vagi-
nalis, and live trichomonads) for 6 h. * p < 0.05 versus RPMC alone. C: RPMC alone. (B) TNF-α mRNA expression of RPMC stimulated 
with 50 % ESP of T. vaginalis for 1 h or 2.
A B
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DISCUSSION
In trichomoniasis, vaginal discharge and vulvova-ginal irritation are known to be the most common presenting complaints. The vulvovaginal pruritus 
or irritation is noted by one fourth to four fifths of 
infected women (Rein, 1989). Additionally, the vaginal 
walls are recognized as erythematous in perhaps 
one-third to two-thirds of patients (Gardner, 1981). 
Increased vascularity and a characteristic vascular pat-
tern in the squamous epithelium of the cervix as well 
as an increased abundance of mast cells in the endo-
cervical smear were described in T. vaginalis cervicitis 
(Kobayashi et al., 1983; Kolstad, 1964; Bergsjoe et al., 
1963; Skrzypiec, 1977). These main signs and symp-
toms suggest that T. vaginalis stimulates an allergic 
reaction. Furthermore, relatively high IgE levels have 
been measured in patients with vaginal trichomoniasis 
and in mice immunized with a soluble antigen of 
T. vaginalis (Yano et al., 1982; Green et al., 1976). 
Although these observations suggest that mast cells 
may be involved in the allergic and cellular reaction 
to vaginal trichomoniasis, involvement of mast cell 
didn’t experimentally proved. From this study, T. va-
ginalis induced an increase in chemotactic migration 
of the mast cells toward T. vaginalis, and the mast 
cells activated with T. vaginalis showed an increased 
release of histamine and TNF-α. These results provide 
experimental confirmation of mast cell involvement in 
T. vaginalis infection. 
Giardia lamblis is similar to T. vaginalis in that they 
are both flagellate protozoans and extracellular para-
sites in humans. Mast cell responses may contribute 
to the pathophysiology of giardiasis in addition to the 
control of infections. Symptoms of giardiasis include 
malabsorptive diarrhea, cramps, and nausea and are 
similar to those noted in food allergies, celiac disease, 
and other intestinal disorders. In several of these 
diseases and in several animal models, mast cells 
have been implicated in contributing to this pathology 
(Farthing, 2003). Additionally, the reported increase 
in serum MCP-1 and histamine levels observed after 
infection of C57BL/6 mice suggest that symptoms of 
giardiasis may be related to allergic processes (Di 
Prisco et al., 1998).
A particular problem of human mast cell research is 
the difficulty in obtaining human cell material for in 
vitro studies. Therefore, most in vitro mast cell expe-
riments have been carried out either with human cell 
materials that might have limited functional signi-
ficance, such as transformed cell lines or partially 
immature mast cells, or with murine primary mast cells 
that can be easily obtained, such as peritoneal mast 
cells. Murine peritoneal cells have been widely used, 
as a single peritoneal lavage yields large numbers of 
mast cells that can be easily purified (Bischoff, 2007). 
Therefore, rat peritoneal mast cells, a primary mast 
cell, were used for this study
In the present study, rat peritoneal mast cells demons-
trated increased migration toward T. vaginalis ESP. 
Interestingly, we and other researchers previously 
described a chemotactic activity of T. vaginalis ESP on 
leukocytes (Mason & Forman, 1982; Park et al., 1984). 
This suggests that T. vaginalis ESP may induce the 
migration of mast cells as well as leukocytes. Although 
the exact component of T. vaginalis ESP, which is 
 chemoattractive is not known, Leukotriene B4 (LTB4) 
in ESP was reported to play a major role in chemo-
tactic activity (Shaio et al., 1992). Further experiment 
will be examined whether anti-LTB4 antibody could 
abolish the chemotactic activity of ESP. 
When mast cells are activated, they immediately 
extrude granule-associated substances such as his-
tamine, and within minutes generate lipid-derived 
mediators (Brody & Metcalfe, 1998) In addition, mast 
cell activation is followed within hours by the de novo 
synthesis of numerous cytokines and chemokines 
(Kobayashi et al., 2000). The production of TNF-α and 
histamine in T. vaginalis-stimulated mast cells were 
increased in dose-dependent manner except those of 
highest concentrations. In further study, application of 
various incubation periods, including shorter incuba-
tion time, for histamine or TNF-α production would 
be required to find reason of the decreased level on 
highest concentration of parasites.
It has been shown that mast cells, and mast cell-
derived TNF, can promote the migration of other 
hematopoietic cell types, including neutrophils, mono-
cytes, and T cells, in the context of both innate and 
acquired immune responses (Suto et al., 2006; Mala-
viya et al., 1996; Biedermann et al., 2000). In addition, 
Fig. 4. – The migration of rat peritoneal mast cells was assessed 
by counting the number of RPMCs which migrated through the 
polycarbonate membrane after treatment with the excretory-secre-
tory products (ESP) of T. vaginalis for 4 h. Stem cell factor (SCF) 
at 100 ng/ml was used as a positive control (P). C: RPMC alone. 
* p < 0.05 versus RPMC alone.
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histamine and TNF produced by IgE- and Ag-activated 
mast cells have been shown to be important for the 
migration of subsets of DCs from the skin and airways 
to the lymph nodes (Gordon & Galli, 1991; Suto et al., 
2006; Jawdat et al., 2004). The production of TNF-α 
and histamine in T. vaginalis-stimulated mast cells 
were shown to increase in this study. Secreted media-
tors including TNF-α and histamine are expected to 
aid in the recruitment of neutrophils, and to initiate 
the subsequent adaptive immune response. Therefore, 
further studies need to be carried out to investigate cell 
migration of other hemopoietic cell types stimulated 
by T. vaginalis.
Therefore, T. vaginalis induced an increase in chemo-
tactic migration of the mast cells toward T. vaginalis, 
and the mast cells activated with T. vaginalis showed 
an increased release of histamine and TNF-α. In con-
clusion, it is suggested that mast cells play a role in 
the inflammation caused by T. vaginalis by producing 
histamine and cytokines. 
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